Tianda Pharmaceuticals (HKSE:00455) Pre-Tax Income : HK$-25.7 Mil (TTM As of Dec. 2023)

Tianda Pharmaceuticals Pre-Tax Income Chart

Tianda Pharmaceuticals Annual Data
	Trend	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Dec23
Pre-Tax Income		Get a 7-Day Free Trial					26.17	15.93	-27.44	-28.02	-25.69

Tianda Pharmaceuticals Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Jun23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial															-18.20	-9.82	-20.20	-5.57	-20.13

Competitive Comparison of Tianda Pharmaceuticals's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Tianda Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tianda Pharmaceuticals's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianda Pharmaceuticals's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Tianda Pharmaceuticals's Pre-Tax Income falls into.

Tianda Pharmaceuticals Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Tianda Pharmaceuticals's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Tianda Pharmaceuticals's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-25.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tianda Pharmaceuticals  (HKSE:00455) Pre-Tax Income Explanation

Tianda Pharmaceuticals's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

During the past 13 years, Tianda Pharmaceuticals's highest Pretax Margin was 26.07%. The lowest was -17.41%. And the median was 4.11%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tianda Pharmaceuticals Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Tianda Pharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianda Pharmaceuticals (HKSE:00455) Business Description